Abstract: A novel weighed and summing bipolar photonic digital-to-analog converter (BPDAC) scheme employing optical differential phase shift keying modulation and balanced detection is proposed and ...

Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key ...

Evommune, Inc. (NYSE: EVMN) (the "Company" or "Evommune"), a clinical-stage biotechnology company developing innovative ...

Findings provide mechanistic support for previously reported clinical outcomes of clinical reversal of platinum resistance/refractoriness from ...

Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced positive topline full study results from the Phase 3 VISIONARY trial. VOYXACT ® ...

Bupropion conferred modest reductions in cancer-related fatigue compared with placebo, according to results of a randomized ...

Abstract: A new approach to modulation classification based on the Kolmogorov-Smirnov (K-S) test is proposed. The K-S test is a non-parametric method to measure the goodness of fit. The basic ...

It's built like a tank and sounds the bomb ...

Advances in soft materials are reshaping the design of next-generation devices, particularly where flexibility, adaptability, ...

The wAIHA market landscape is undergoing a significant evolution after years of dependence on broad immunosuppressive ...

A new approach for identifying signs of hidden awareness in people who cannot speak or move after severe brain injury has ...